These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 24125420

  • 1. Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.
    Jovanovich A, Ix JH, Gottdiener J, McFann K, Katz R, Kestenbaum B, de Boer IH, Sarnak M, Shlipak MG, Mukamal KJ, Siscovick D, Chonchol M.
    Atherosclerosis; 2013 Nov; 231(1):114-9. PubMed ID: 24125420
    [Abstract] [Full Text] [Related]

  • 2. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA.
    Clin J Am Soc Nephrol; 2018 Jan 06; 13(1):45-52. PubMed ID: 29025789
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease.
    Seifert ME, de las Fuentes L, Ginsberg C, Rothstein M, Dietzen DJ, Cheng SC, Ross W, Windus D, Dávila-Román VG, Hruska KA.
    Am J Nephrol; 2014 Jan 06; 39(5):392-9. PubMed ID: 24818573
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.
    Akhabue E, Wong M, Mehta R, Isakova T, Wolf M, Yancy C, Gutierrez OM, Carnethon M.
    Am Heart J; 2022 Mar 06; 245():10-18. PubMed ID: 34861237
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
    Ruebner RL, Ng D, Mitsnefes M, Foster BJ, Meyers K, Warady B, Furth SL.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1962-1968. PubMed ID: 27630183
    [Abstract] [Full Text] [Related]

  • 6. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
    Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE.
    Atherosclerosis; 2009 Dec 07; 207(2):546-51. PubMed ID: 19524924
    [Abstract] [Full Text] [Related]

  • 7. QTc Interval Prolongation Is Independently Associated with FGF23 and Predicts Mortality in Predialysis Chronic Kidney Disease.
    Sikaneta T, Ho N, Bellasi A, Mahdavi S, Taskapan H, Svendrovski A, Makanjee B, Roberts J, Wu G, Nathoo B, Tam P.
    Cardiorenal Med; 2024 Dec 07; 14(1):45-57. PubMed ID: 37963445
    [Abstract] [Full Text] [Related]

  • 8. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M, Große Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, Klintschar M, Becker JU, Erbersdobler A, Aufricht C, Seeman T, Fischer DC, Faul C, Haffner D.
    Nephrol Dial Transplant; 2016 Jul 07; 31(7):1088-99. PubMed ID: 26681731
    [Abstract] [Full Text] [Related]

  • 9. Fibroblast growth factor 23 in chronic kidney disease: bridging the gap between bone mineral metabolism and left ventricular hypertrophy.
    Canziani ME, Tomiyama C, Higa A, Draibe SA, Carvalho AB.
    Blood Purif; 2011 Jul 07; 31(1-3):26-32. PubMed ID: 21135546
    [Abstract] [Full Text] [Related]

  • 10. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
    Sinha MD, Turner C, Booth CJ, Waller S, Rasmussen P, Goldsmith DJ, Simpson JM.
    Pediatr Nephrol; 2015 Oct 07; 30(10):1843-52. PubMed ID: 25975437
    [Abstract] [Full Text] [Related]

  • 11. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M, Santos-Araújo C, Poínhos R, Oliveira B, Silva IS, Silva LS, Sousa MJ, Correia F, Pestana M.
    Clin Nephrol; 2016 Mar 07; 85(3):135-41. PubMed ID: 26833300
    [Abstract] [Full Text] [Related]

  • 12. Hypericin Alleviates Chronic Kidney Disease-induced Left Ventricular Hypertrophy by Regulation of FGF23-FGFR4 Signaling Pathway.
    Liu M, Cheng L, Ye Q, Liu H, Shu C, Gao H, Liu X, Zhang X, Chen G.
    J Cardiovasc Pharmacol; 2024 Jun 01; 83(6):588-601. PubMed ID: 38547517
    [Abstract] [Full Text] [Related]

  • 13. Left ventricular hypertrophy and geometry in type 2 diabetes patients with chronic kidney disease. An echocardiographic study.
    Bayauli MP, Lepira FB, Kayembe PK, M'buyamba-Kabangu JR.
    Cardiovasc J Afr; 2012 Mar 01; 23(2):73-7. PubMed ID: 22447475
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA, Eisenga MF, van Ballegooijen AJ, Beulens JWJ, Vervloet MG, Navis G, Gansevoort RT, Bakker SJL, De Borst MH.
    Nephrol Dial Transplant; 2021 Jan 01; 36(1):121-128. PubMed ID: 32124925
    [Abstract] [Full Text] [Related]

  • 15. FGF23 induces left ventricular hypertrophy.
    Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M.
    J Clin Invest; 2011 Nov 01; 121(11):4393-408. PubMed ID: 21985788
    [Abstract] [Full Text] [Related]

  • 16. Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.
    Brady TM, Roem J, Cox C, Schneider MF, Wilson AC, Furth SL, Warady BA, Mitsnefes M.
    Am J Kidney Dis; 2020 Aug 01; 76(2):166-173. PubMed ID: 32389356
    [Abstract] [Full Text] [Related]

  • 17. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB.
    Clin J Am Soc Nephrol; 2016 Nov 07; 11(11):1989-1998. PubMed ID: 27561289
    [Abstract] [Full Text] [Related]

  • 18. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S, Fujita S, Kizawa S, Morita H, Ishizaka N.
    PLoS One; 2016 Nov 07; 11(7):e0156860. PubMed ID: 27400031
    [Abstract] [Full Text] [Related]

  • 19. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
    Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.
    JAMA Cardiol; 2016 Aug 01; 1(5):548-56. PubMed ID: 27434583
    [Abstract] [Full Text] [Related]

  • 20. Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease.
    Watanabe K, Fujii H, Okamoto K, Kono K, Goto S, Nishi S.
    Front Endocrinol (Lausanne); 2023 Aug 01; 14():1276664. PubMed ID: 38174329
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.